Overdiagnosis of thyroid cancer persists
Overdiagnosis of thyroid cancer in the United States remains a persistent problem, according to a study published online Feb. 5 in The Lancet Diabetes & Endocrinology.
Feb 12, 2025
0
9
Endocrine System Diseases: News and Research on Thyroid Neoplasms
MeSH tree: C19.344.894
Glucagon-like peptide-1 receptor agonists tied to higher thyroid cancer risk in first year of treatment
The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a study published online ...
Jan 30, 2025
0
24
FDA bans Red 3 dye from food and drugs. A scientist explains the artificial color's health risks and long history
Red 3—also called FD&C Red No. 3, erythrosine or E127—has been widely used in food, cosmetics and pharmaceuticals since its FDA approval in 1969. You've likely encountered Red 3 before. It's a common additive to many candies, ...
Jan 23, 2025
0
15
Years of experience support the safe use of fine-needle aspiration for pediatric thyroid nodules
Ultrasound-guided fine-needle aspiration (FNA) has long been used as a safe and effective way to evaluate thyroid nodules in adults, usually without sedation. Less is known about the safety and tolerability of FNA in children, ...
Jan 22, 2025
0
10
Children born to young men with cancer have increases in preterm birth, low-birthweight children, but not birth defects
Male adolescents and young adults with cancer have a slightly elevated risk of having preterm birth and children with low birth weight, but no increased risk of birth defects in their offspring, according to research by UTHealth ...
Jan 16, 2025
0
13
US bans controversial red food dye, decades after scientists raised alarm
Outgoing US President Joe Biden's administration on Wednesday announced a ban on Red Dye No 3, a controversial food and drug coloring long known to cause cancer in animals.
Jan 15, 2025
0
17
Study finds no elevated risk of thyroid cancer among GLP1-RA users
A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased risk of thyroid cancer.
Jan 13, 2025
0
15
Study: Suicide rates for young male cancer survivors triple in recent years, with ages 15–39 seeing highest rate
New research published in JAMA Network Open from USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, suggests that among all cancer survivors, male adolescents and young adults (AYA) have the highest rate ...
Nov 18, 2024
0
34
Cancer diagnoses linked to lasting financial challenges, studies find
A diagnosis of cancer can take a toll on more than a person's health. Researchers at Beth Israel Deaconess Medical Center and Harvard Medical School in Boston found that financial fallout can follow patients with cancer and ...
Oct 18, 2024
0
21
Melanoma risk increased after radioactive iodine treatment for primary thyroid cancer, study finds
Patients with primary thyroid cancer who receive radioactive iodine therapy have an elevated risk for melanoma and other nonkeratinocyte skin cancers when limiting the cancer site to the head and neck, according to a study ...
Sep 27, 2024
0
31
